We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+8.99%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$21.9B
AUM Growth
+$21.9B
(+100,205%)
Cap. Flow
-$417M
Cap. Flow
% of AUM
-1.9%
Top 10 Holdings %
Top 10 Hldgs %
13.08%
Holding
3,337
New
135
Increased
1,103
Reduced
1,007
Closed
163
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$89.3M |
| 2 |
Keysight
KEYS
|
+$86M |
| 3 |
Nike
NKE
|
+$78.3M |
| 4 |
Amphenol
APH
|
+$76.5M |
| 5 |
Comcast
CMCSA
|
+$72.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Celanese
CE
|
+$108M |
| 2 |
Monster Beverage
MNST
|
+$97.8M |
| 3 |
Starbucks
SBUX
|
+$79.7M |
| 4 |
Texas Instruments
TXN
|
+$67.3M |
| 5 |
Centene
CNC
|
+$64.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.83% |
| 2 | Financials | 13.42% |
| 3 | Healthcare | 13.25% |
| 4 | Industrials | 9.77% |
| 5 | Consumer Discretionary | 7.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Public Storage
PSA
$60.5B
| $1.21M | 0.01% |
5,686
-2,839
| -33% | -$630K |
|
627
Intuitive Surgical
ISRG
$128B
| $1.21M | 0.01% |
6,120
-57
| -0.9% | -$10.7K |
|
628
CF Industries
CF
$18.4B
| $1.2M | 0.01% |
25,193
-64
| -0.3% | -$3K |
|
|
CDK
629
DELISTED
CDK Global, Inc.
CDK
| $1.17M | 0.01% |
21,340
-402
| -2% | -$20.7K |
|
630
BorgWarner
BWA
$13.1B
| $1.15M | 0.01% |
30,199
+3,074
| +11% | +$113K |
|
631
Lincoln National
LNC
$7.88B
| $1.14M | 0.01% |
19,368
-11,006
| -36% | -$648K |
|
632
TransDigm Group
TDG
$71.9B
| $1.13M | 0.01% |
2,025
-4
| -0.2% | -$2.19K |
|
633
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.3B
| $1.13M | 0.01% |
18,003
+4,425
| +33% | +$273K |
|
|
CUK
634
DELISTED
Carnival PLC
CUK
| $1.11M | 0.01% |
23,186
+22,708
| +4,751% | +$960K |
|
635
Mesa Laboratories
MLAB
$540M
| $1.11M | 0.01% |
4,438
+2,153
| +94% | +$504K |
|
636
NOV
NOV
$7.35B
| $1.1M | 0.01% |
44,169
+7,660
| +21% | +$172K |
|
637
Western Union
WU
$2.55B
| $1.1M | 0.01% |
41,167
+33,120
| +412% | +$859K |
|
638
Liberty Broadband Class C
LBRDK
$4.44B
| $1.09M | 0.01% |
8,717
| – | – |
|
639
Oshkosh
OSK
$9.66B
| $1.09M | 0.01% |
11,560
+6,925
| +149% | +$597K |
|
640
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.66B
| $1.08M | ﹤0.01% |
14,700
| – | – |
|
641
Unilever
UL
$132B
| $1.08M | ﹤0.01% |
16,794
-44,393
| -73% | -$2.95M |
|
642
Brookfield
BN
$103B
| $1.07M | ﹤0.01% |
51,761
-824
| -2% | -$16.4K |
|
643
Ralph Lauren
RL
$22.6B
| $1.05M | ﹤0.01% |
9,005
+184
| +2% | +$19.4K |
|
644
iShares Gold Trust
IAU
$63.4B
| $1.04M | ﹤0.01% |
35,788
-1
| -0% | -$28 |
|
645
Sanofi
SNY
$105B
| $1.03M | ﹤0.01% |
20,635
-44,097
| -68% | -$2.07M |
|
|
WCG
646
DELISTED
Wellcare Health Plans, Inc.
WCG
| $1.03M | ﹤0.01% |
3,132
-28
| -0.9% | -$8.4K |
|
647
VanEck Gold Miners ETF
GDX
$23.2B
| $1.02M | ﹤0.01% |
34,851
-1,030
| -3% | -$28.2K |
|
648
Mohawk Industries
MHK
$7.05B
| $1.01M | ﹤0.01% |
7,448
-416
| -5% | -$56.6K |
|
649
Vulcan Materials
VMC
$36.9B
| $1.01M | ﹤0.01% |
7,002
+107
| +2% | +$15.3K |
|
|
PDCE
650
DELISTED
PDC Energy, Inc.
PDCE
| $1M | ﹤0.01% |
38,310
+267
| +0.7% | +$6.41K |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q4 2019 Portfolio in Review
As of Q4 2019, Glenmede Trust held 3,337 positions worth $21.9B, up 100,205% from $21.9M the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Glenmede Trust's Q4 2019 filing shows 135 new, 1,103 increased, 1,007 reduced and 163 closed positions. Its largest new stake was Callon Petroleum Company: 285,674 shares worth $13.8M. The largest sale was Celanese, an estimated $108M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- Glenmede Trust's largest Q4 2019 buy was Callon Petroleum Company: 285,674 shares worth $13.8M.
- Glenmede Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $89.3M increase.
- Glenmede Trust's biggest Q4 2019 reduction was Celanese, cutting an estimated $108M.
- Glenmede Trust fully exited Celgene Corp in Q4 2019, selling an estimated $122K.
- Glenmede Trust's ten largest holdings make up 13% of its $21.9B portfolio in Q4 2019.
- Glenmede Trust opened 135 new positions and closed 163 in Q4 2019.
- Glenmede Trust's portfolio value rose 100,205% quarter-over-quarter to $21.9B.
Based on Glenmede Trust's 13F filing for Q4 2019, filed 12 Feb 2020.